Beida Pharmaceutical (000788.SZ) released the performance for the first three quarters, with a net profit attributable to the parent company of 136 million yuan, an increase of 4.31%.

Wisdom Finance APP News, Beida Medicine (000788.SZ) released its third quarter report for 2025. The company's operating income for the first three quarters was 1.231 billion yuan, a decrease of 19.76% year-on-year. The net profit attributable to shareholders of the listed company was 136 million yuan, an increase of 4.31% year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 126 million yuan, a decrease of 2.66% year-on-year. Basic earnings per share were 0.2282 yuan.